MatchaDB

2023期刊论文可免费阅读

Editorial: Women in gastrointestinal cancers, volume II: 2022

Nadia Μ. Hamdy, Lisardo Boscá, Sukh Mahendra Singh, Srinivasa Reddy Bonam, Igor Kišš, Divya P. Kumar, Aditi Banerjee

Frontiers in Oncology

在出版方阅读→免费全文→PubMed

摘要

Women in Gastrointestinal Cancer Vol II: 2022 EDITORIAL This editorial presents the inaugural Frontiers in Oncology (FIO) 'Women in Gastrointestinal Cancer Vol II: 2022" series of article collections. The research topic collection highlights the diversity of research performed across the entire breadth of oncology research by women scientists pursuing STEM careers. Nine (9) research articles, from 14 submitted to FIO within this section, published under this research topic by 92 authors, aimed to present advances in theory, experiment, and methodology, with applications to compelling problems related to gastric cancers: gastrointestinal (GI) cancer: Hepato-Pancreatic Biliary (HPB) cancers. 1/9 is a brief research report article titled "the BET inhibitor JQ1 potentiates the anticlonogenic effect of radiation in pancreatic cancer cells". 1/9 is a case report article titled "a female with synchronous multiple primary malignant tumors in the esophagogastric junction, duodenum, and pancreas: Case report and review of the literature". Methodology Clinical trial article 1/9 under the title "implementing pharmacogenetic testing in gastrointestinal cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 screening to guide chemotherapy dosing". Four out of the nine (4/9) published articles are original research articles exploring the tumor-immune interactions in the tumor microenvironment (TME) and identifying new prognostic and/or therapeutic biomarkers to assist in novel decoding mechanism(s) of tumor immunotherapy as well as being confined with personalized treatment based on geno/pheno-typic evaluations. These four articles are, first "Evaluation of Galanin Expression in Colorectal Cancer (CRC): An Immunohistochemical (IHC)…

摘要已缩短。在来源处阅读完整摘要。

摘要文本来自PubMed、OpenAlex或Europe PMC,版权归作者和出版方所有。

研究类型

系统综述/荟萃分析

对既往研究进行结构化检索并合并分析。

根据标题、摘要和主题词自动分配。

主题

抹茶是这里的主要研究对象(出现在关键词中)。

关键词与主题词

你的研究文件夹

引用这项研究

Nadia Μ. Hamdy, Lisardo Boscá, Sukh Mahendra Singh, Srinivasa Reddy Bonam, Igor Kišš, Divya P. Kumar, Aditi Banerjee. (2023). Editorial: Women in gastrointestinal cancers, volume II: 2022. Frontiers in Oncology. https://doi.org/10.3389/fonc.2023.1192814

DOI:10.3389/fonc.2023.1192814 · PubMed ID:37265801

更多关于代谢与体重

2018期刊论文可免费阅读

Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways.

Bonuccelli G, Sotgia F, Lisanti MP — Aging

Matcha green tea (MGT) is a natural product that is currently used as a dietary supplement and may have significant anti-cancer properties. However, the molecular mechanism(s) underpinning its potential health benefits remain largely…

体外/细胞研究代谢与体重抗氧化物与多酚癌症被引用75次
2020期刊论文

Changes in Intestinal Microbiota of Type 2 Diabetes in Mice in Response to Dietary Supplementation With Instant Tea or Matcha.

Zhang HH, Liu J, Lv YJ等 — Canadian journal of diabetes

Objective: Gut microbiota plays a key role in metabolism and health in diabetes patients with gastrointestinal microbiota dysbiosis. Thus, regulating the ecological balance of gut microbiota may provide a pathway toward improvement for…

动物研究代谢与体重肠道与微生物组市场、文化与可持续性被引用74次

浏览整个研究库→